DENGUE

 ( SEVAMED 2002)

(Diagnosis, Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis, Vaccines & Drugs)

Click Here for Abstract

Back To Content Page  

3183.      Chaturvedi UC.  Elbishbishi EA.  Agarwal R. Mustafa AS. Cytotoxic factor-autoantibodies: possible role in the pathogenesis of dengue haemorrhagic fever. FEMS Immunology & Medical Microbiology.  30(3):181-6, 2001 Apr.

3184.      Cohen J.  'Breeding' antigens for new vaccines.  Science.  293(5528):236-8, 2001 Jul 13.

3185.      Gagnon SJ.  Leporati A.  Green S. Kalayanarooj S.  Vaughn DW. Stephens HA.   Suntayakorn S.  Kurane I.  Ennis FA.  Rothman AL. T cell receptor Vbeta gene usage in Thai children with dengue virus infection. American Journal of Tropical Medicine & Hygiene.  64(1-2):41-8, 2001 Jan-Feb.

3186.      Juffrie M.  Meer GM.  Hack CE.  Haasnoot K.  Sutaryo. Veerman AJ.  Thijs LG. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. American Journal of Tropical Medicine & Hygiene. 65(1):70-5, 2001 Jul.

3187.            Kanesa-thasan N.  Sun W.  Kim-Ahn G.  Van Albert S.  Putnak JR.  King A.  Raengsakulsrach B. Christ-Schmidt H.  Gilson K.  Zahradnik JM.  Vaughn DW.   Innis BL. Saluzzo JF.  Hoke CH Jr. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine. 19(23-24):3179-88, 2001 Apr 30.

3188.      Lok SM.  Ng ML.  Aaskov J. Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody. Journal of Medical Virology.  65(2):315-23, 2001 Oct.

3189.      Mustafa AS.  Elbishbishi EA.  Agarwal R. Chaturvedi UC. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunology & Medical Microbiology. 30(3):229-33, 2001 Apr.

3190.      Saeed MF.  Nunes M.  Vasconcelos PF.  Travassos Da Rosa AP.  Watts DM.  Russell K. Shope RE.  Tesh RB. Barrett AD. Diagnosis of Oropouche virus infection using a recombinant nucleocapsid protein-based enzyme immunoassay. Journal of Clinical Microbiology.  39(7):2445-52, 2001 Jul.

3191.      Sullivan NJ.  Antibody-mediated enhancement of viral disease. [Review] [128 refs] Current Topics in Microbiology & Immunology.  260:145-69, 2001.

3192.      Tolou HJ.  Couissinier-Paris P.  Durand JP. Mercier V.  de Pina JJ. de Micco P. Billoir F.  Charrel RN.  de Lamballerie X. Evidence for recombination in natural populations of dengue virus type 1 based on the analysis of complete genome sequences. Journal of General Virology. 82(Pt 6):1283-90, 2001 Jun.

3193.      Vasconcelos PF.  Luna EJ.  Galler R.  Silva LJ.  Coimbra TL. Barros VL.  Monath TP. Rodigues SG.  Laval C.  Costa ZG. Vilela MF. Santos CL. Papaiordanou CM.  Alves VA. Andrade LD.  Sato HK.  Rosa ES. Froguas GB.  Lacava E. Almeida LM. Cruz AC.  Rocco IM.  Santos RT. Oliva OF.  Brazilian Yellow Fever Vaccine Evaluation Group.  Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. [see comments]. Lancet.  358(9276):91-7, 2001 Jul 14.

3194.            Wu HC.  Huang YL.  Chao TT. Jan JT.  Huang JL. Chiang HY.  King CC.  Shaio MF. Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients. Journal of Clinical Microbiology.  39(3):977-82, 2001 Mar.

Apr 02

3996.      Barrett AD. Current status of flavivirus vaccines. Ann N Y Acad Sci  2001 Dec;951:262-71

3997.      Blaney JE Jr, Johnson DH, Firestone CY, Hanson CT, Murphy BR, Whitehead SS. Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice. J Virol  2001 Oct;75(20):9731-40

3998.      Chang GJ, Davis BS, Hunt AR, Holmes DA, Kuno G. Flavivirus DNA vaccines: current status and potential. Ann N Y Acad Sci 2001 Dec;951:272-85

3999.      Cuzzubbo AJ, Endy TP, Nisalak A, Kalayanarooj S, Vaughn DW, Ogata SA, Clements DE, Devine PL. Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay. Clin Diagn Lab Immunol 2001 Nov;8(6):1150-5

4000.      Gomber S, Ramachandra n V G, Satish Kumar, Agarwal K N, Gupta P, Gupta P, Dewan D K: Hematological observation as diagnostic markers in dengue hemorrhagic fever. Indian Pediat 2001, 38(5), 477-81.(015304). Aug 1, 2001.

4001.      Huang JL, Huang JH, Shyu RH, Teng CW, Lin YL, Kuo MD, Yao CW, Shaio MF. High level expression of recombinant dengue viral NS-1 protein and its potential use as a diagnostic antigen. J Med Virol  2001 Nov;65(3):553-60

4002.      Openshaw PJ, Culley FJ, Olszewska W. Immunopathogenesis of vaccine-enhanced RSV disease. Vaccine  2001 Oct 15;20 Suppl 1:S27-31

4003.      Pea L, Roda L, Moll F. Desmopressin treatment for a case of dengue hemorrhagic fever/dengue shock syndrome. Clin Infect Dis 2001 Nov 1;33(9):1611-2

4004.      Troyer JM, Hanley KA, Whitehead SS, Strickman D, Karron RA, Durbin AP, Murphy BR. A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes. Am J Trop Med Hyg 2001 Nov;65(5):414-9

July 02

4540.      Arora MM; Mishra KB; Nair V; Bhardwaj JR; Bhalwar R; Somani BL. Diagnosing disseminated intravascular coagulation in acute infection : can we do without FDP & D-DIMER Medical Journal Armed Forces India 2002 Jan; 58(1): 13-7

4541.      Cao XT, Ngo TN, Wills B, Kneen R, Nguyen TT, Ta TT, Tran TT, Doan TK, Solomon T, Simpson JA, White NJ, Farrar JJ. Evaluation of the World Health Organization standard tourniquet test and a modified tourniquet test in the diagnosis of dengue infection in Viet Nam. Trop Med Int Health. 2002 Feb;7(2):125-32.

4542.      da Fonseca BA, Fonseca SN. Dengue virus infections. Curr Opin Pediatr. 2002 Feb;14(1):67-71. Review.

4543.      Gasem MH, Smits HL, Goris MG, Dolmans WM. Evaluation of a simple and rapid dipstick assay for the diagnosis of typhoid fever in Indonesia. J Med Microbiol. 2002 Feb;51(2):173 7.

4544.      Guzman MG, Kouri G. Dengue: an update.Lancet Infect Dis. 2002 Jan;2(1):33-42. Review.

4545.      Monath TP, Arroyo J, Levenbook I, Zhang ZX, Catalan J, Draper K, Guirakhoo F. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J Virol. 2002 Feb;76(4):1932-43.

Oct 02

5218.      Bartley LM, Carabin H, Vinh Chau N, Ho V, Luxemburger C, Hien TT, Garnett GP, Farrar J. Assessment of the factors associated with flavivirus seroprevalence in a population in Southern Vietnam. Epidemiol Infect. 2002 Apr;128(2):213-20.

5219.      Branch SL, Levett PN. Evaluation of four methods for detection of immunoglobulin M antibodies to dengue virus. Clin Diagn Lab Immunol. 1999 Jul;6(4):555-7.

5220.      De Paula SO, Lopes da Fonseca BA. Optimizing dengue diagnosis by RT-PCR in IgM-positive samples: comparison of whole blood, buffy-coat and serum as clinical samples. J Virol Methods. 2002 Apr;102(1-2):113-7.

5221.      Groen J, Koraka P, Velzing J, Copra C, Osterhaus AD. Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies. Clin Diagn Lab Immunol. 2000 Nov;7(6):867-71.

5222.      Lum LC, Goh AY, Chan PW, El-Amin AL, Lam SK. Risk factors for hemorrhage in severe dengue infections. J Pediatr. 2002 May;140(5):629-31.

5223.      Palmer CJ, King SD, Cuadrado RR, Perez E, Baum M, Ager AL. Evaluation of the MRL diagnostics dengue fever virus IgM capture ELISA and the PanBio Rapid Immunochromatographic Test for diagnosis of dengue fever in Jamaica. J Clin Microbiol. 1999 May;37(5):1600-1.

5224.      Porter KR, Widjaja S, Lohita HD, Hadiwijaya SH, Maroef CN, Suharyono W, Tan R.  Evaluation of a commercially available immunoglobulin M capture enzyme-linked immunosorbent assay kit for diagnosing acute dengue infections. Clin Diagn Lab Immunol. 1999 Sep;6(5):741-4.

5225.      Spiegel J, Yassi A, Tate R. Dengue in Cuba: mobilisation against Aedes aegypti. Lancet Infect Dis. 2002 Apr;2(4):207-8.

5226.      van Gorp EC, Suharti C, Mairuhu AT, Dolmans WM, van Der Ven J, Demacker PN, van Der Meer JW. Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. Clin Infect Dis. 2002 Apr 15;34(8):1150-3.

5227.      Vaughn DW, Endy TP. Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children. Emerg Infect Dis. 2002 May;8(5):485-9.

5228.      Warrilow D, Northill JA, Pyke A, Smith GA. Single rapid TaqMan fluorogenic probe based PCR assay that detects all four dengue serotypes. J Med Virol. 2002 Apr;66(4):524-8.

5229.    Wu SJ, Paxton H, Hanson B, Kung CG, Chen TB, Rossi C, Vaughn DW, Murphy GS, Hayes CG.  Comparison of two rapid diagnostic assays for detection of immunoglobulin M antibodies to dengue virus. Clin Diagn Lab Immunol. 2000 Jan;7(1):106-10.

5230.      Yamada K, Takasaki T, Nawa M, Kurane I. Virus isolation as one of the diagnostic methods for dengue virus infection. J Clin Virol. 2002 Apr;24(3):203-9.

Pathogenesis:

5231.      Wang WK, Lin SR, Lee CM, King CC, Chang SC. Dengue type 3 virus in plasma is a population of closely related genomes: quasispecies. J Virol. 2002 May;76(9):4662-5.

  Vaccines :

 5232. Clarke T. Dengue virus: break-bone fever. Nature  2002 Apr 18;416(6882):672-4